Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany
- 1 March 1985
- journal article
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 63 (5), 233-235
- https://doi.org/10.1007/bf01731176
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A glycopolypeptide (gp 100) is the main antigen detected by HTLV-III antiseraMedical Microbiology and Immunology, 1985
- HETEROSEXUAL PARTNERS: A LARGE RISK GROUP FOR AIDSThe Lancet, 1984
- INFECTION OF CHIMPANZEES WITH LYMPHADENOPATHY-ASSOCIATED VIRUSThe Lancet, 1984
- INCREASE IN PREVALENCE OF ANTI-HTLV-III IN HAEMOPHILIACSThe Lancet, 1984
- ANTIBODIES TO HTLV-III IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY OR LYMPHADENOPATHY SYNDROME IN WEST GERMANYThe Lancet, 1984
- Transmission of HTLV-III Infection from Human Plasma to Chimpanzees: An Animal Model for AIDSScience, 1984
- Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T LymphocytesScience, 1984
- SEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROMEThe Lancet, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Antikörper gegen menschliches T-Zell-Leukämie-Virus Typ III bei erworbenem Immundefekt-Syndrom und persistierender LymphadenopathieDeutsche Medizinische Wochenschrift (1946), 1984